| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918530 | Radiotherapy and Oncology | 2014 | 5 Pages |
Abstract
V50 was a significant risk factor for ⩾grade 2 RIBI after CIRT using a 16-fraction regimen.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Masashi Koto, Azusa Hasegawa, Ryo Takagi, Akira Fujikawa, Takamichi Morikawa, Riwa Kishimoto, Keiichi Jingu, Hirohiko Tsujii, Tadashi Kamada,